Covea Finance Buys 29,600 Shares of Xylem Inc. (NYSE:XYL)

Covea Finance grew its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 38.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 106,286 shares of the industrial products company's stock after buying an additional 29,600 shares during the period. Covea Finance's holdings in Xylem were worth $12,331,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp increased its position in Xylem by 1.9% during the 3rd quarter. State Street Corp now owns 10,329,494 shares of the industrial products company's stock valued at $1,394,792,000 after purchasing an additional 189,820 shares during the period. Geode Capital Management LLC increased its position in shares of Xylem by 1.0% during the third quarter. Geode Capital Management LLC now owns 5,668,755 shares of the industrial products company's stock valued at $762,804,000 after buying an additional 54,877 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Xylem by 1.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company's stock valued at $465,760,000 after buying an additional 32,645 shares during the period. Swedbank AB raised its stake in Xylem by 22.8% in the third quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company's stock worth $403,953,000 after buying an additional 554,609 shares in the last quarter. Finally, Impax Asset Management Group plc lifted its holdings in Xylem by 1.0% in the third quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company's stock worth $226,555,000 after buying an additional 15,825 shares during the period. Institutional investors own 87.96% of the company's stock.

Xylem Stock Up 0.6 %

Xylem stock traded up $0.68 during mid-day trading on Wednesday, reaching $116.10. The stock had a trading volume of 1,339,956 shares, compared to its average volume of 1,274,581. Xylem Inc. has a one year low of $109.39 and a one year high of $146.08. The company has a 50-day moving average price of $121.41 and a two-hundred day moving average price of $129.06. The company has a market capitalization of $28.21 billion, a price-to-earnings ratio of 33.95, a PEG ratio of 2.22 and a beta of 1.06. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.96 and a quick ratio of 1.42.

Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.11. The firm had revenue of $2.10 billion for the quarter, compared to the consensus estimate of $2.17 billion. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The business's revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.99 earnings per share. On average, analysts expect that Xylem Inc. will post 4.23 EPS for the current fiscal year.

Xylem Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 24th. Shareholders of record on Tuesday, November 26th were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date of this dividend was Tuesday, November 26th. Xylem's payout ratio is 42.11%.

Analysts Set New Price Targets

XYL has been the topic of a number of research analyst reports. Royal Bank of Canada reduced their target price on Xylem from $163.00 to $162.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Citigroup reduced their price target on Xylem from $148.00 to $147.00 and set a "buy" rating on the stock in a research note on Monday. Stifel Nicolaus lowered their price objective on Xylem from $172.00 to $166.00 and set a "buy" rating for the company in a research report on Wednesday, December 11th. TD Cowen reduced their target price on shares of Xylem from $138.00 to $125.00 and set a "hold" rating on the stock in a research report on Wednesday, November 6th. Finally, Robert W. Baird decreased their price target on shares of Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a research note on Friday, November 1st. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $152.10.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.